Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Journal of Proteomics|April 19, 2015
Evaluation of different phospho-tyrosine antibodies for label-free phosphoproteomicsJohannes C van der Mijn, Mariette Labots, Sander R Piersma, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 9, 2010
Staphylococcal SSL5 binding to human leukemia cells inhibits cell adhesion to endothelial cells and plateletsAnnemiek M E Walenkamp, Jovanka Bestebroer, Ingrid G J Boer, et al.
Current Pharmaceutical Design|September 15, 2012
Molecular mechanisms and modulation of key pathways underlying the synergistic interaction of sorafenib with erlotinib in non-small-cell-lung cancer (NSCLC) cellsE Giovannetti, M Labots, H Dekker, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Benchmarking cancer outcomes in Europe: a scoping review of methodologies and case-mix adjustmentsJ Thurell, L Doppelbauer, E M Verheul, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|April 13, 2010
Simple and selective method for the determination of various tyrosine kinase inhibitors used in the clinical setting by liquid chromatography tandem mass spectrometryR Honeywell, K Yarzadah, E Giovannetti, et al.
Neurology|February 11, 2012
SMN1 gene duplications are associated with sporadic ALSH M Blauw, C P Barnes, P W J van Vught, et al.
The Journal of Molecular Diagnostics : JMD|March 20, 2012
KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNADaniëlle A M Heideman, Irene Lurkin, Marije Doeleman, et al.
Clinical Immunology (Orlando, Fla.)|May 19, 2016
Differential effects of inhibitors of the PI3K/mTOR pathway on the expansion and functionality of regulatory T cellsCharlotte M Huijts, Saskia J Santegoets, Maria Quiles Del Rey, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2015
PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximabNikolaos E Makris, Ronald Boellaard, Arthur van Lingen, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|April 10, 2024
Patient-reported esthetic outcomes following lower extremity free flap reconstruction: A cross-sectional multicenter studyDavid D Krijgh, Emile B List, Brent Beljaars, et al.
Pageof 12